We report the synthesis and characterization of two different types of Ni-based laminated composites (Types I and II). In Type-I composites, layers of Ni and Ti3SiC2 (Ni–Ti3SiC2) were interleaved with Ni, whereas in Type-II composites, Ni–Ti3SiC2 layers were interleaved with Al and Ni. The laminate thickness and Ti3SiC2 content in the individual Ni–Ti3SiC2 layers were systematically varied in both the composites. Detailed SEM studies showed that Ti3SiC2 particulates are well distributed in the Ni-matrix with little or no interfacial reactions with interparticle porosity. However, there were interfacial reactions between Ni and Al in Type II composites. In general, Type I multilayered composites had higher ultimate compressive strength (UCS) in parallel orientation as compared to perpendicular orientation (layers are aligned parallel or perpendicular to the wear surface then it will be referred to as parallel or perpendicular orientation). Comparatively, in Type II composites, the UCS was greater in perpendicular orientation as compared to parallel due to the presence of Al layers as bonding layers. Both the composite designs showed triboactive behavior against alumina disks and sensitivity to laminate thickness and orientation. In Type-I composites, the decrease in µ and wear rate (WR) with laminate thickness was more pronounced in the perpendicular orientation as compared to the parallel orientation. Comparatively, Ni–Ti3SiC2/Al/Ni composites showed that the parallel orientation was more effective in enhancing the triboactive performance. SEM analysis of tribosurfaces showed signs of triboxidation and abrasion, which led to the formation of O-rich tribofilms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.